Reports from Cancer Center advance knowledge in clinical pharmacy

New investigation results, "Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management," are detailed in a study published in Journal of Clinical Pharmacy & Therapeutics. "Older oncology patients with multiple comorbidities are at risk for adverse drug events associated with polypharmacy and drug-drug interactions due to patients' altered pharmacokinetic/pharmacodynamic status and the narrow therapeutic windows associated with anti-neoplastic agents. This study addresses the issue of polypharmacy and potential drug-drug interactions in outpatients in a community setting in the USA, and the prescribing behaviour of oncologists...

Want to see the full article?

• Purchase this article for only $3.00